Immunic, Inc. Stock-Based Compensation
Immunic, Inc. (IMUX) reported Stock-Based Compensation of $11.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-11
- Immunic, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $6.78M, a 257.14% increase year-over-year.
- Immunic, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $4.47M, a 118.71% increase year-over-year.
- Immunic, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.31M, a 34.11% decline year-over-year.
- Immunic, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $3.61M, a 89.21% increase year-over-year.
- Immunic, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $8.86M, a 3.94% increase from fiscal 2024.
- Immunic, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $8.53M, a 20.06% increase from fiscal 2023.
- Immunic, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $7.10M, a 10.43% decline from fiscal 2022.
- Immunic, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $7.93M, a 33.28% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed | Share-based Payment Arrangement, Noncash Expense 130 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $11.25M 10-Q · filed 2026-08-11 | $12.56M derived: sum of 3 quarters · filed 2026-08-11 | $16.17M derived: sum of 4 quarters · filed 2026-08-11 | |||||
| 2026-03-31 | $4.47M 10-Q · filed 2026-05-13 | $5.77M derived: sum of 2 quarters · filed 2026-05-13 | $9.39M derived: sum of 3 quarters · filed 2026-05-13 | $11.29M derived: sum of 4 quarters · filed 2026-08-11 | |||||
| 2025-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.92M derived: sum of 2 quarters · filed 2026-02-26 | $6.82M derived: sum of 3 quarters · filed 2026-08-11 | $8.86M 10-K · filed 2026-02-26 | |||||
| 2025-09-30 | $3.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $5.51M derived: sum of 2 quarters · filed 2026-08-11 | $7.55M 10-Q · filed 2025-11-13 | $9.54M derived: sum of 4 quarters · filed 2026-08-11 | |||||
| 2025-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $3.94M 10-Q · filed 2026-08-11 | $5.93M derived: sum of 3 quarters · filed 2026-08-11 | $7.84M derived: sum of 4 quarters · filed 2026-08-11 | |||||
| 2025-03-31 | $2.04M 10-Q · filed 2026-05-13 | $4.03M derived: sum of 2 quarters · filed 2026-05-13 | $5.94M derived: sum of 3 quarters · filed 2026-05-13 | $7.82M derived: sum of 4 quarters · filed 2026-05-13 | |||||
| 2024-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.90M derived: sum of 2 quarters · filed 2026-02-26 | $5.78M derived: sum of 3 quarters · filed 2026-02-26 | $8.53M 10-K · filed 2026-02-26 | |||||
| 2024-09-30 | $1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.79M derived: sum of 2 quarters · filed 2025-11-13 | $6.54M 10-Q · filed 2025-11-13 | $8.18M derived: sum of 4 quarters · filed 2025-11-13 | |||||
| 2024-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $4.63M 10-Q · filed 2025-08-07 | $6.27M derived: sum of 3 quarters · filed 2025-08-07 | $7.96M derived: sum of 4 quarters · filed 2025-08-07 | |||||
| 2024-03-31 | $2.75M 10-Q · filed 2025-05-15 | $4.39M derived: sum of 2 quarters · filed 2025-05-15 | $6.08M derived: sum of 3 quarters · filed 2025-05-15 | $7.87M derived: sum of 4 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.33M derived: sum of 2 quarters · filed 2025-03-31 | $5.12M derived: sum of 3 quarters · filed 2025-03-31 | $7.10M 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.48M derived: sum of 2 quarters · filed 2024-11-07 | $5.46M 10-Q · filed 2024-11-07 | $7.35M derived: sum of 4 quarters · filed 2024-11-07 | |||||
| 2023-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.78M 10-Q · filed 2024-08-08 | $5.66M derived: sum of 3 quarters · filed 2024-08-08 | $7.58M derived: sum of 4 quarters · filed 2024-08-08 | |||||
| 2023-03-31 | $1.98M 10-Q · filed 2024-05-08 | $3.87M derived: sum of 2 quarters · filed 2024-05-08 | $5.78M derived: sum of 3 quarters · filed 2024-05-08 | $7.84M derived: sum of 4 quarters · filed 2024-05-08 | |||||
| 2022-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $3.80M derived: sum of 2 quarters · filed 2024-02-22 | $5.86M derived: sum of 3 quarters · filed 2024-02-22 | $7.93M 10-K · filed 2024-02-22 | |||||
| 2022-09-30 | $1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $3.97M derived: sum of 2 quarters · filed 2023-11-14 | $6.04M 10-Q · filed 2023-11-14 | $7.51M derived: sum of 4 quarters · filed 2023-11-14 | |||||
| 2022-06-30 | $2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $4.13M 10-Q · filed 2023-08-03 | $5.60M derived: sum of 3 quarters · filed 2023-08-03 | $6.99M derived: sum of 4 quarters · filed 2023-08-03 | |||||
| 2022-03-31 | $2.07M 10-Q · filed 2023-05-11 | $3.54M derived: sum of 2 quarters · filed 2023-05-11 | $4.93M derived: sum of 3 quarters · filed 2023-05-11 | $6.44M derived: sum of 4 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.86M derived: sum of 2 quarters · filed 2023-02-23 | $4.37M derived: sum of 3 quarters · filed 2023-02-23 | $5.95M 10-K · filed 2023-02-23 | |||||
| 2021-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $2.90M derived: sum of 2 quarters · filed 2022-11-03 | $4.48M 10-Q · filed 2022-11-03 | $5.80M derived: sum of 4 quarters · filed 2022-11-03 | |||||
| 2021-06-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.09M 10-Q · filed 2022-08-04 | $4.40M derived: sum of 3 quarters · filed 2022-08-04 | $5.11M derived: sum of 4 quarters · filed 2022-08-04 | |||||
| 2021-03-31 | $1.58M 10-Q · filed 2022-05-10 | $2.90M derived: sum of 2 quarters · filed 2022-05-10 | $3.60M derived: sum of 3 quarters · filed 2022-05-10 | $3.97M derived: sum of 4 quarters · filed 2022-05-10 | |||||
| 2020-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.02M derived: sum of 2 quarters · filed 2022-02-24 | $2.39M derived: sum of 3 quarters · filed 2022-02-24 | $2.75M 10-K · filed 2022-02-24 | |||||
| 2020-09-30 | $707.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.08M derived: sum of 2 quarters · filed 2021-11-04 | $1.43M 10-Q · filed 2021-11-04 | $1.76M derived: sum of 4 quarters · filed 2021-11-04 | |||||
| 2020-06-30 | $369.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $722.00K 10-Q · filed 2021-08-06 | $1.05M derived: sum of 3 quarters · filed 2021-08-06 | $1.25M derived: sum of 4 quarters · filed 2021-08-06 | |||||
| 2020-03-31 | $353.00K 10-Q · filed 2021-05-06 | $683.00K derived: sum of 2 quarters · filed 2021-05-06 | $882.00K derived: sum of 3 quarters · filed 2021-05-06 | $6.87M derived: sum of 4 quarters · filed 2021-05-06 | |||||
| 2019-12-31 | $330.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $529.00K derived: sum of 2 quarters · filed 2021-02-26 | $6.51M derived: sum of 3 quarters · filed 2021-02-26 | $6.51M 10-K · filed 2021-02-26 | |||||
| 2019-09-30 | $199.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $6.18M derived: sum of 2 quarters · filed 2020-11-06 | $6.18M 10-Q · filed 2020-11-06 | $6.18M derived: sum of 4 quarters · filed 2020-11-06 | |||||
| 2019-06-30 | $5.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $5.98M 10-Q · filed 2020-08-03 | $5.98M derived: sum of 3 quarters · filed 2020-08-03 | $5.98M derived: sum of 4 quarters · filed 2020-08-03 | |||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-08 | $6.10M 10-Q · filed 2019-04-10 | $0.00 derived: sum of 2 quarters · filed 2020-05-08 | $0.00 derived: sum of 3 quarters · filed 2020-05-08 | -$1.55M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $0.00 derived: sum of 2 quarters · filed 2020-03-16 | -$1.55M derived: sum of 3 quarters · filed 2020-03-16 | $0.00 10-K · filed 2020-03-16 | $3.74M 10-K · filed 2019-03-04 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$1.55M derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | $3.10M 10-Q · filed 2018-11-08 | $1.84M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | $3.36M 10-Q · filed 2018-08-07 | $1.84M derived: sum of 3 quarters · filed 2019-08-08 | $3.06M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $1.55M 10-Q · filed 2019-04-10 | $3.39M derived: sum of 2 quarters · filed 2019-04-10 | $4.61M derived: sum of 3 quarters · filed 2019-04-10 | $5.77M derived: sum of 4 quarters · filed 2019-04-10 | |||||
| 2017-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-04 | $3.06M derived: sum of 2 quarters · filed 2019-03-04 | $4.22M derived: sum of 3 quarters · filed 2019-03-04 | $5.48M 10-K · filed 2019-03-04 | |||||
| 2017-09-30 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $2.38M derived: sum of 2 quarters · filed 2018-11-08 | $3.64M 10-Q · filed 2018-11-08 | $4.93M derived: sum of 4 quarters · filed 2019-03-04 | |||||
| 2017-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $2.42M 10-Q · filed 2018-08-07 | $3.71M derived: sum of 3 quarters · filed 2019-03-04 | $5.09M derived: sum of 4 quarters · filed 2019-03-04 | |||||
| 2017-03-31 | $1.26M 10-Q · filed 2018-05-08 | $2.55M derived: sum of 2 quarters · filed 2019-03-04 | $3.93M derived: sum of 3 quarters · filed 2019-03-04 | $4.94M derived: sum of 4 quarters · filed 2019-03-04 | |||||
| 2016-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-04 | $2.67M derived: sum of 2 quarters · filed 2019-03-04 | $3.68M derived: sum of 3 quarters · filed 2019-03-04 | $4.68M 10-K · filed 2019-03-04 | |||||
| 2016-09-30 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | $2.39M derived: sum of 2 quarters · filed 2017-10-25 | $3.39M 10-Q · filed 2017-10-25 | $4.48M derived: sum of 4 quarters · filed 2018-03-13 | |||||
| 2016-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $2.01M 10-Q · filed 2017-08-03 | $3.09M derived: sum of 3 quarters · filed 2018-03-13 | $4.24M derived: sum of 4 quarters · filed 2018-03-13 | |||||
| 2016-03-31 | $998.00K 10-Q · filed 2017-05-09 | $2.08M derived: sum of 2 quarters · filed 2018-03-13 | $3.23M derived: sum of 3 quarters · filed 2018-03-13 | $4.22M derived: sum of 4 quarters · filed 2018-03-13 | |||||
| 2015-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $2.23M derived: sum of 2 quarters · filed 2018-03-13 | $3.23M derived: sum of 3 quarters · filed 2018-03-13 | $4.03M 10-K · filed 2018-03-13 | |||||
| 2015-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $2.14M derived: sum of 2 quarters · filed 2016-11-03 | $2.94M 10-Q · filed 2016-11-03 | $3.69M derived: sum of 4 quarters · filed 2017-03-07 | |||||
| 2015-06-30 | $998.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $1.80M 10-Q · filed 2016-08-02 | $2.55M derived: sum of 3 quarters · filed 2017-03-07 | $3.20M derived: sum of 4 quarters · filed 2017-03-07 | |||||
| 2015-03-31 | $803.00K 10-Q · filed 2016-05-09 | $1.55M derived: sum of 2 quarters · filed 2017-03-07 | $2.21M derived: sum of 3 quarters · filed 2017-03-07 | $2.88M derived: sum of 4 quarters · filed 2017-03-07 | |||||
| 2014-12-31 | $745.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $1.40M derived: sum of 2 quarters · filed 2017-03-07 | $2.08M derived: sum of 3 quarters · filed 2017-03-07 | $2.51M 10-K · filed 2017-03-07 | |||||
| 2014-09-30 | $657.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $1.33M derived: sum of 2 quarters · filed 2015-11-05 | $1.76M 10-Q · filed 2015-11-05 | $2.12M derived: sum of 4 quarters · filed 2016-03-08 | |||||
| 2014-06-30 | $673.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $1.11M 10-Q · filed 2015-08-06 | $1.47M derived: sum of 3 quarters · filed 2016-03-08 | $1.76M derived: sum of 4 quarters · filed 2016-03-08 | |||||
| 2014-03-31 | $435.00K 10-Q · filed 2015-05-12 | $792.00K derived: sum of 2 quarters · filed 2016-03-08 | $1.08M derived: sum of 3 quarters · filed 2016-03-08 | $1.28M derived: sum of 4 quarters · filed 2016-03-08 | $1.76M 10-Q · filed 2014-05-28 | ||||
| 2013-12-31 | $357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $649.00K derived: sum of 2 quarters · filed 2016-03-08 | $843.00K derived: sum of 3 quarters · filed 2016-03-08 | $948.00K 10-K · filed 2016-03-08 | |||||
| 2013-09-30 | $292.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $486.00K derived: sum of 2 quarters · filed 2014-11-13 | $591.00K 10-Q · filed 2014-11-13 | ||||||
| 2013-06-30 | $194.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $299.00K 10-Q · filed 2014-08-07 | |||||||
| 2013-03-31 | $105.00K 10-Q · filed 2014-05-28 | ||||||||
| 2012-12-31 | $144.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |